Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME® trial

by Takashi Kadowaki, Masaomi Nangaku, Stefan Hantel, Tomoo Okamura, Maximilian vonEynatten, Christoph Wanner, Audrey Koitka‐Weber
Published 2019-05-01

Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease

by Anna M. D. Watson, Anna M. D. Watson, Eleanor A. M. Gould, Sarah C. Moody, Priyadharshini Sivakumaran, Karly C. Sourris, Bryna S. M. Chow, Audrey Koïtka-Weber, Terri J. Allen, Karin A. M. Jandeleit-Dahm, Karin A. M. Jandeleit-Dahm, Mark E. Cooper, Mark E. Cooper, Anna C. Calkin, Anna C. Calkin
Published 2020-06-01